Status           

Study

Link to clinicaltrials.gov

Ongoing,
not recruiting

Use of NATPARA in the Treatment of Hypoparathyroidism (REPLACE)

http://clinicaltrials.gov/ct2/show/NCT00732615?term=parathyroid+hormone+1-84&rank=12

Enrolling
by invitation

ADD-ON Study to
Existing Hypoparathyroidism Studies

http://clinicaltrials.gov/ct2/show/NCT00856401?term=parathyroid+hormone+1-84&rank=1

Enrolling
by invitation

A 12-Month Open-label Study
Investigating the Safety and Tolerability of NATPARA, a Recombinant Human Parathyroid Hormone
(rhPTH [1-84]), for the Treatment of Adults with Hypoparathyroidism
- A Clinical Extension Study (RACE)

http://clinicaltrials.gov/ct2/show/NCT01297309?term=parathyroid+hormone+1-84&rank=2

Active,
recruiting

A Study to Investigate the Safety and Efficacy of a Recombinant Human Parathyroid Hormone for the Treatment of Adults with Hypoparathyroidism (RELAY)

http://clinicaltrials.gov/ct2/show/NCT01268098?term=parathyroid+hormone+1-84&rank=3

Enrolling
by invitation

Open-label Extension Study of
PTH (1-84)

http://clinicaltrials.gov/ct2/show/NCT01199614?term=parathyroid+hormone+1-84&rank=4

  Investigator-initiated studies:

Ongoing,
but not recruiting

Bone Properties in Hypoparathyroidism:
Effects of PTH

http://clinicaltrials.gov/ct2/show/NCT00473265?term=parathyroid+hormone+1-84&rank=15

Completed

Treatment of Hypoparathyroidism with Subcutaneous PTH (1-84) Injections:
Effects on Muscle Function and Quality of Life (HypoPTH)

http://clinicaltrials.gov/ct2/show/NCT00730210?term=parathyroid+hormone+1-84&rank=8